ArticleThe Pan African medical journal2025
Bilateral adrenal tumors presenting with Cushing syndrome in the setting of horseshoe kidney: surgical and urological considerations (case report).
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Simultaneous bilateral adrenal masses are less common in patients with Cushing syndrome (CS). This case report focuses on the clinical features, diagnostic workup, and treatment of a patient with bilateral adrenal tumors causing Cushing syndrome, with a horseshoe kidney. We report a case of bilateral adrenal tumors presenting with Cushing syndrome with a horseshoe kidney. Adrenalectomy was undertaken to manage the excess cortisol. Histopathological evaluation confirmed the diagnosis of adrenal cortical carcinoma (ACC). The preoperative cortisol level was 1750 nmol/L, which dropped significantly to 476 nmol/L following the treatment, showing clinical improvement, with a gradual regression of Cushing syndrome symptoms. A three-month postoperative evaluation revealed cortisol levels of 143 nmol/L. Surgical resection of these tumors has the potential to significantly improve clinical outcomes and alleviate the manifestations of Cushing syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.